Monday, May 11, 2026
ISSN 2765-8767
  • Survey
  • Podcast
  • Write for Us
  • My Account
  • Log In
Daily Remedy
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
  • Home
  • Articles
  • Podcasts
    How NADAC, WAC, and ASP Shape Drug Costs

    How NADAC, WAC, and ASP Shape Drug Costs

    April 20, 2026
    The Hidden Costs Employers Don’t See in Traditional Health Plans

    The Hidden Costs Employers Don’t See in Traditional Health Plans

    March 22, 2026
    The Impact of COVID-19 on Patient Trust

    The Impact of COVID-19 on Patient Trust

    March 3, 2026
    Debunking Myths About GLP-1 Medications

    Debunking Myths About GLP-1 Medications

    February 16, 2026
    The Future of LLMs in Healthcare

    The Future of LLMs in Healthcare

    January 26, 2026
    The Future of Healthcare Consumerism

    The Future of Healthcare Consumerism

    January 22, 2026
  • Surveys

    Surveys

    Public Perception of Peptide Regulation and Compounding Practices

    Public Perception of Peptide Regulation and Compounding Practices

    April 19, 2026
    Understanding of Clinical Evidence in Peptide and Hormone Use

    Understanding of Clinical Evidence in Peptide and Hormone Use

    March 30, 2026

    Survey Results

    Can you tell when your provider does not trust you?

    Can you tell when your provider does not trust you?

    January 18, 2026
    Do you believe national polls on health issues are accurate

    National health polls: trust in healthcare system accuracy?

    May 8, 2024
    Which health policy issues matter the most to Republican voters in the primaries?

    Which health policy issues matter the most to Republican voters in the primaries?

    May 14, 2024
    How strongly do you believe that you can tell when your provider does not trust you?

    How strongly do you believe that you can tell when your provider does not trust you?

    May 7, 2024
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner
No Result
View All Result
Daily Remedy
No Result
View All Result
Home Contrarian

Does COVID-19 Mutate Rapidly?

Daily Remedy by Daily Remedy
August 24, 2021
in Contrarian
0

“All that you touch you change. All that you change, changes you. The only lasting truth is change”, author and futurist Octavia E. Butler wrote.

An apt quotation as the world grapples with a never ending series of COVID-19 viral variants. Since the virus first emerged from China in December 2019, it has spread across the world. And in its spread, it has mutated repeatedly. But to understand why COVID-19 has mutated like it has, we must understand the basics of viral mutations.

COVID-19 is an RNA based virus. These types of viruses mutate at a faster rate than their DNA based counterparts. Mutations occur over infection cycles, a term infectious disease experts use to describe the life cycle of a viral infection, in which the virus enters a host, replicates inside, and then spreads from the host to others.

A study out of Portugal found the rate of spontaneous mutation in COVID-19, or more formally, SARS-CoV-2, is 0.1 per genome per infection cycle, slower than most RNA viruses. But just 10 months after COVID-19 was first discovered, researchers out of Duke University catalogued more than 12,000 mutations.

At first it may appear odd that a virus with a slow mutation rate has so many mutations, many of which make the virus more infectious. But oddly enough, it makes perfect sense, because there is a difference between the frequency of individual mutations, and the total mutations seen.

Infectious disease specialists differentiate mutation frequency as the proportion of mutations in a population, and mutation rate as the rate at which mutations occur in a viral genome.

COVID-19 has spread across the world in a year, an unprecedented reach for a novel virus. In its spread, it incurred numerous infection cycles, giving it plenty of opportunities to mutate.

And mutate it has, though at a much slower rate than when it first appeared. Most of the variants we are now learning about through the news cycles were discovered months ago.

According to the WHO database on COVID-19 virus variants, the delta variant was discovered in India in October 2020 and the lambda variant was discovered in Peru in August 2020. In fact, the WHO documented the latest variant, theta, in January 2021. No additional variants have been discovered since.

This bodes well for a global population that struggles to distribute its vaccines and unable to shake off its lingering vaccine hesitancy.

“This variant now is the pandemic. As a result, its properties matter,” wrote Nathan Grubaugh, a viral epidemiologist at the Yale School of Public Health.

This means the course of the pandemic hinges on the rate of COVID-19 mutations.

Most of the mutations have produced variants that are more infectious, a lucky break we may lose if the mutations result in variants resistant to the acquired immunity derived from vaccines.

Regardless of whether we are vaccinated or symptomatic, when we come in contact with another person, we give the virus an opportunity to spread – and mutate – as it spreads through an infection cycle.

Studies suggest the viral mutations have optimized its infectivity rates, but it can still mutate to be resistant to available treatments.

While we have quickly developed treatments, therapeutics, and vaccines to combat the symptoms produced by the virus, we have nothing to stop the transmission of the virus or its ability to mutate.

In July 2021, researchers in Germany published data on six immunocompromised patients with COVID-19 who were treated with monoclonal antibodies. In five of them, the virus acquired a mutation known for eluding the immune system, and the virus rebounded in all five patients.

There is no definite treatment for COVID-19. It is a virus. The only treatment is to control the symptoms of the disease to where we can live normal lives.

That means balancing the viral mutations with the available treatments and vaccines.

We seem to be edging out the virus in this regard. But like all things related to COVID-19, the battle is evolving, and will be won through a shift in perception more than any scientific breakthrough.

We may need to accept localized lockdowns and mask-wearing and social distancing as a part of our everyday lives for the foreseeable future. That may mean for us to accept public health policies even when the virus appears to be gone or diminished.

This would be a change.

We must recognize that the cure for COVID-19 is not some drug or complex immunomodulation therapy. The treatment has nothing to do with technology and everything to do with simple behavioral changes that we are all capable of.

This would be a change.

At a fundamental level, a mutation is nothing more than a change. The virus changes every time it comes in contact with anyone of us. We must also learn to change.

That is the only treatment.

ShareTweet
Daily Remedy

Daily Remedy

Dr. Jay K Joshi serves as the editor-in-chief of Daily Remedy. He is a serial entrepreneur and sought after thought-leader for matters related to healthcare innovation and medical jurisprudence. He has published articles on a variety of healthcare topics in both peer-reviewed journals and trade publications. His legal writings include amicus curiae briefs prepared for prominent federal healthcare cases.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Videos

summary

An in-depth exploration of drug pricing, including key databases like NADAC, WAC, and ASP, and how they influence the pharmaceutical supply chain, policy, and patient advocacy. The episode also introduces MedPricer's innovative pricing intelligence platform, offering valuable insights for healthcare professionals, policymakers, and patients.

Chapters

00:00 Understanding Drug Pricing Dynamics
03:52 Exploring the Drug Pricing Database
10:07 Patient Advocacy and Drug Pricing
13:56 Market Intelligence in Drug Pricing
How NADAC, WAC, and ASP Shape Drug CostsDaily Remedy
YouTube Video X-Tfwy7XKEg
Subscribe

Policy Shift in Peptide Regulation

Clinical Reads

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation

by Daily Remedy
April 19, 2026
0

Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...

Read more

Join Our Newsletter!

Twitter Updates

Tweets by TheDailyRemedy

Popular

  • Geographic Price Dispersion as a Macro Signal: What Hospital Rate Variance Tells Investors About Regional Economic Health

    The Gross-to-Net Bubble

    0 shares
    Share 0 Tweet 0
  • The Rebate That Ate the List Price

    0 shares
    Share 0 Tweet 0
  • Transparency Without Translation

    0 shares
    Share 0 Tweet 0
  • Twenty-Eight Times Wrong

    0 shares
    Share 0 Tweet 0
  • Two Headed Monster Returns

    1 shares
    Share 0 Tweet 0
  • 628 Followers

Daily Remedy

Daily Remedy offers the best in healthcare information and healthcare editorial content. We take pride in consistently delivering only the highest quality of insight and analysis to ensure our audience is well-informed about current healthcare topics - beyond the traditional headlines.

Daily Remedy website services, content, and products are for informational purposes only. We do not provide medical advice, diagnosis, or treatment. All rights reserved.

Important Links

  • Support Us
  • About Us
  • Contact us
  • Privacy Policy
  • Terms and Conditions

Join Our Newsletter!

  • Survey
  • Podcast
  • About Us
  • Contact us

© 2026 Daily Remedy

No Result
View All Result
  • Home
  • Articles
  • Podcasts
  • Surveys
  • Courses
  • About Us
  • Contact us
  • Support Us
  • Official Learner

© 2026 Daily Remedy